Aro Biotherapeutics
James McKenney is a Scientist III in Protein Engineering at Aro Biotherapeutics since March 2021. Prior to this role, James held a position in Quality Control Testing at WuXi Advanced Therapies from January 2019 to 2021. James graduated from the University of Delaware in 2018 with a Bachelor of Arts in Biology/Biological Sciences.
Aro Biotherapeutics
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.